trending Market Intelligence /marketintelligence/en/news-insights/trending/6aE7NkTd6d2q6xuamafbLg2 content esgSubNav
In This List

CRISPR Therapeutics appoints board chairman

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


CRISPR Therapeutics appoints board chairman

CRISPR Therapeutics AG named Rodger Novak as board chairman.

Novak is the founder and former CEO of CRISPR Therapeutics. He will succeed Tony Coles, who will remain with the company as a senior adviser.